MDT vs. BMY, ISRG, SYK, GILD, ELV, SNY, VRTX, REGN, ZTS, and BSX
Should you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include Bristol-Myers Squibb (BMY), Intuitive Surgical (ISRG), Stryker (SYK), Gilead Sciences (GILD), Elevance Health (ELV), Sanofi (SNY), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Zoetis (ZTS), and Boston Scientific (BSX). These companies are all part of the "medical" sector.
Bristol-Myers Squibb (NYSE:BMY) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.
Bristol-Myers Squibb has higher revenue and earnings than Medtronic. Bristol-Myers Squibb is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.
In the previous week, Bristol-Myers Squibb had 4 more articles in the media than Medtronic. MarketBeat recorded 24 mentions for Bristol-Myers Squibb and 20 mentions for Medtronic. Medtronic's average media sentiment score of 0.89 beat Bristol-Myers Squibb's score of 0.68 indicating that Bristol-Myers Squibb is being referred to more favorably in the media.
75.0% of Bristol-Myers Squibb shares are held by institutional investors. Comparatively, 80.8% of Medtronic shares are held by institutional investors. 0.1% of Bristol-Myers Squibb shares are held by company insiders. Comparatively, 0.3% of Medtronic shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Medtronic received 505 more outperform votes than Bristol-Myers Squibb when rated by MarketBeat users. Likewise, 76.70% of users gave Medtronic an outperform vote while only 67.08% of users gave Bristol-Myers Squibb an outperform vote.
Bristol-Myers Squibb has a net margin of 18.44% compared to Bristol-Myers Squibb's net margin of 12.83%. Medtronic's return on equity of 51.59% beat Bristol-Myers Squibb's return on equity.
Bristol-Myers Squibb presently has a consensus target price of $63.59, indicating a potential upside of 26.39%. Medtronic has a consensus target price of $93.33, indicating a potential upside of 17.62%. Given Medtronic's higher possible upside, analysts clearly believe Bristol-Myers Squibb is more favorable than Medtronic.
Bristol-Myers Squibb pays an annual dividend of $2.28 per share and has a dividend yield of 4.5%. Medtronic pays an annual dividend of $2.76 per share and has a dividend yield of 3.5%. Bristol-Myers Squibb pays out 57.9% of its earnings in the form of a dividend. Medtronic pays out 89.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bristol-Myers Squibb has raised its dividend for 14 consecutive years and Medtronic has raised its dividend for 47 consecutive years. Bristol-Myers Squibb is clearly the better dividend stock, given its higher yield and lower payout ratio.
Bristol-Myers Squibb has a beta of 0.34, suggesting that its share price is 66% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500.
Summary
Bristol-Myers Squibb beats Medtronic on 11 of the 21 factors compared between the two stocks.
Get Medtronic News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Medtronic Competitors List
Related Companies and Tools